Billy Tauzin

From Powerbase
Jump to: navigation, search
Billy Tauzin is a former US congressman turned influential lobbyist. In 2005 he became President and Chief Executive Officer of the drug industry's main trade group, The Pharmaceutical Research and Manufacturers of America (PhRMA), shortly after leaving politics. Tauzin, who resigned from PhRMA in June 2010, was considered key to positioning the pharmaceutical industry firmly behind the Obama administration's health care reforms 'after reaching a deal with the White House aimed at limiting damage to the industry'. [1]
Courtesy of PhRMA website
[2] In 2008 he earned $2,055,445. His total compensation, including bonus, incentives and other stuff, was $4,476,157. [3]


According to his PhRMA profile in 2008:

"Billy Tauzin began his public service career in the Louisiana State Legislature where he served in a variety of distinguished posts such as Chairman of the House Natural Resources Committee and Chief Administration Floor Leader. He was chosen twice as one of Louisiana's "Ten Best Legislators."

"He was first elected to the U.S. House in 1980 as a Democrat. Because his conservative views increasingly led him to vote with GOP House members despite his Democratic affiliation, he switched parties in 1995. In 1998, he joined with House Majority Leader Dick Armey to propose a revamping of the tax code. While in Congress, he held several leadership positions, beginning with his chairmanship of a Merchant Marine Subcommittee, which oversaw legislation related to the Exxon Valdez oil spill in Alaska. In September 1995 he was named Deputy Majority Whip; he is the first American to have been part of the leadership of both parties in the House. In an effort to promote a spirit of bipartisan cooperation on Capitol Hill, he co-founded and served as Co-Chairman of the Mainstream Conservative Alliance, better known as Republican "Blue Dogs."

Until February, 2004, he served as the Chairman of the influential House Committee on Energy and Commerce, which has jurisdiction over all interstate and foreign commerce, including energy, telecommunications, health care, biomedical research, consumer protection, the environment and travel and tourism. During his tenure, he left his mark on issues ranging from natural gas, airline, trucking and electricity deregulation to the Clean Air Act, Superfund and the historic Telecommunications Reform Act of 1996. In addition, he was the original author of the Securities Litigation Reform Act and the Cable Act – the only bills over the past decade to become law despite a Presidential veto. As chairman of the House Committee on Energy and Commerce, he helped President George W. Bush win passage of a Medicare prescription drug bill." [4]


  1. Dan Eggen, Billy Tauzin, key player in health-care push, leaving PhRMA, The Washington Post, 13 February 2010, accessed 20 September 2010.
  2. About Billy Accessed 2nd March 2008
  3. Matthew Dalton, What Does a Top EU Lobbyist Earn, WSJ Real Time Brussels, 17 September, 2010, accessed same day.
  4. About Billy Accessed 2nd March 2008